Defining the role of GLP-1 receptor agonists for individualized treatment of type 2 diabetes (original) (raw)
Related papers
The American Journal of Medicine, 2011
Arquivos Brasileiros de Endocrinologia & Metabologia, 2008
The Incretin Approach for Diabetes Treatment: Modulation of Islet Hormone Release by GLP-1 Agonism
Diabetes, 2004
GLP-1 receptor agonists in the treatment of type 2 diabetes: role and clinical experience to date
Postgraduate Medicine
European Journal of Endocrinology, 2008
Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
Therapeutics and Clinical Risk Management
Canadian Journal of Diabetes, 2012
Incretin-Based Therapies in Type 2 Diabetes Mellitus
The Journal of Clinical Endocrinology & Metabolism, 2008
Mayo Clinic Proceedings, 2010
Incretin based therapies for type 2 diabetes mellitus
Journal of the Indian Medical Association, 2008
Current Issues in GLP-1 Receptor Agonist Therapy for Type 2 Diabetes
Zachary Bloomgarden, Carol Wysham
Endocrine Practice, 2012
Incretin-based therapies: focus on effects beyond glycemic control alone
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2013
Incretins: Their physiology and application in the treatment of diabetes mellitus
Diabetes/Metabolism Research and Reviews, 2014
Diabetes, 2014
Incretin System: Recent Advances in Glucagon Like Peptide-1 and Dipeptidyl Peptidase-4 Inhibitors
Journal of Patan Academy of Health Sciences, 2015
An Update in Incretin-Based Therapy: A Focus on Glucagon-Like Peptide-1 Receptor Agonists
Diabetes Technology & Therapeutics, 2012
Beyond glucose: cardiovascular effects of incretins and dipeptidyl peptidase-4 substrates
European Heart Journal Supplements, 2012
Effects of Incretin Mimetic Drugs on Diabetic Cardiovascular Functions
2017
The open medicinal chemistry journal, 2011
Adapting the GLP-1-Signaling System to the Treatment of Type 2 Diabetes
Current Diabetes Reviews, 2007
Management of type 2 diabetes: the GLP-1 pathway
Future Prescriber, 2008
From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy
Experimental Diabetes Research, 2011
GLP-1 based therapy for type 2 diabetes
European Journal of Pharmaceutical Sciences, 2006
The incretin system and its role in type 2 diabetes mellitus
Molecular and Cellular Endocrinology, 2009
Current Opinion in Pharmacology, 2004
Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes
Diabetes & Metabolism, 2008
Incretins: Beyond type 2 diabetes
Diabetes, Obesity and Metabolism
Diabetes Research and Clinical Practice, 2007
An Overview of Incretin-Based Therapies: Pharmacology and Future Perspectives
Bulletin of Pharmaceutical Sciences. Assiut
Current Opinion in Endocrinology & Diabetes, 2005
Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1
Diabetes/Metabolism Research and Reviews, 2002
Review Article Advances in pharmacotherapy of Type-2 diabetes (Part-2: The incretin mimetics)
Sudan medical journal
GLP-1 receptor agonists for type 2 diabetes
The Lancet, 2009